BioSpace News Archive

Daré Bioscience, Inc., a leader in women’s health innovation, reported financial results for the year ended December 31, 2020 and provided a company update.

Ovid Therapeutics Inc. (NASDAQ: OVID) (“Ovid”), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced the closing of the Royalty, License and Termination agreement (the “Agreement”) under which Takeda Pharmaceutical secured global rights from Ovid to develop and commercialize the investigational medicine soticlestat (TAK-935/OV935)

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for inflammatory diseases and cancers, is pleased to announce that the U.S. Food and Drug Administration has allowed evaluation of nasal administration with Foralumab, a fully human anti-CD3 monoclonal antibody, in a secondary progressive multiple sclerosis patient at the Brigham and Women’s Hospital, Harvard University, Boston, MA.

BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular and pulmonary regenerative therapies, today reported financial results for the fourth quarter and full year ended December 31, 2020 and recent business highlights

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced Mr. Moshe Mizrahy, Chairman and Chief Executive Officer, Dr. Michael Kreindel, co-founder and Chief Technology Officer, Mr. Yair Malca, Chief Financial Officer, Dr. Spero Theodorou, M.D., Chief Medical Officer, and Mr. Shakil Lakhani,

Aulos Bioscience, a biotechnology company developing highly differentiated interleukin-2 (IL-2)-binding monoclonal antibodies as therapeutics against solid tumors, announced today the appointment of Mace Rothenberg, M.D., to the company’s board of directors.

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced its financial results for the year ended December 31, 2020

Medical device innovator PainTEQ announced the appointment of Timothy Deer, MD, DABPM, to its Scientific Advisory Board. Deer is president and CEO of The Spine & Nerve Centers in Charleston, West Virginia.

Better Therapeutics, Inc., a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, announced the appointments of Andrew Armanino and Geoffrey Parker to its board of directors.

Since 1979, Huntleigh, a member of the Arjo family, has strived to provide patients and the professionals who care for them, innovative solutions that improve outcomes and enhance patient well being, from the safe delivery of a new life to the day-to-day quality of life.